TheProfitWatch

INM - InMed Pharmaceuticals Inc. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.14 0.05 (4.39%) --- --- 0.0 (0.0%) 0.06 (5.26%) 0.02 (1.71%) -0.04 (-3.21%) 0.0 (0.0%)

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.94
Diluted EPS:
-1.94
Basic P/E:
-0.6134
Diluted P/E:
-0.6134
RSI(14) 1m:
40.0
VWAP:
1.2
RVol:

Events

Period Kind Movement Occurred At

Related News